Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans

European Journal of Endocrinology

Volumn 149, Issue 4, 2003, Pages 301-306

  Yamashita, Hiroyuki ^c   Gao, Ping ^a   Cantor, Tom ^a   Futata, Tetsuhiro ^c   Murakami, Tsukasa ^c   Uchino, Shinya ^c   Watanabe, Shin ^c   Kawamoto, Hitoshi ^c   Fukagawa, Masafumi ^b   Noguchi, Shiro ^c  

^a Scantibodies Laboratory Inc   (United States)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hospital Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HALF LIFE TIME; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; IMMUNORADIOMETRIC ASSAY; IMMUNOREACTIVITY; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RAT;

ADENOMA; AGED; FEMALE; HALF-LIFE; HUMANS; HYPERPARATHYROIDISM; JUGULAR VEINS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PEPTIDE FRAGMENTS;

EID: 0142247464     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490301     Document Type: Article

References (28)

1. Silverman R & Yalow RS. Heterogeneity of parathyroid hormone: clinical and physiologic implications. Journal of Clinical Investigation 1973 52 1958-1971.
2. Daugaard H, Egfjord M & Olgaard K. Influence of calcium on the metabolism of intact parathyroid hormone by isolated rat kidney and liver. Endocrinology 1990 126 1813-1820.
3. Hruska KA, Martin K, Mennes P, Greenwalt A, Anderson C, Klahr S et al. Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney: the effect of glomerular filtration rate and perfusate Ca++ concentrations. Journal of Clinical Investigation 1977 60 501-510.
4. Bringhurst FR, Stern AM, Yotts M, Mizrahi N, Segre GV & Potts JT. Peripheral metabolism of PTH: fate of the biologically active amino-terminus in vivo. American Journal of Physiology 1988 241 E208-E211.
5. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clinical Chemistry 1987 33 1364-1367.
6. Kao PC, van Heerden JA, Grant CS, Klee GG & Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clinic Proceedings 1992 67 637-645.
7. Brossard JH, Whittom S, Lepage R & D'Amour P. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions. Journal of Clinical Endocrinology and Metabolism 1993 77 413-419.
8. Gao P, Fulla Y, Scheibel S, Vuillemard C & Cantor T. Recognition of the PTH (7-84) fragment by 5 commercial PTH 'sandwich' assays. Journal of Bone and Mineral Research 2000 15 S564.
9. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G et al. A novel mechanism for skeletal resistance in uremia. Kidney International 2000 58 753-761.
10. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone (1-84): implication for improvement of accurate assessment of parathyroid function. Journal of Bone and Mineral Research 2001 16 605-614.
11. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clinical Chemistry 1998 44 805-809.
12. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB & Juppner H. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. Journal of Clinical Endocrinology and Metabolism 1999 84 4287-4290.
13. Habener JF, Kemper B & Potts JT. Calcium-dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology 1975 97 431-441.
14. Mayer GP, Keaton JA, Hurst JG & Habener JF. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 1979 104 1778-1784.
15. D'Amour P, Palardy J, Bahsali G, Mallette LE, Delean A & Lepage R. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. Journal of Clinical Endocrinology and Metabolism 1992 74 525-532.
16. Faugere MC, Langub MC & Malluche HH. The effects of PTH-(1-84) on bone turnover are antagonized by PTH-(7-84) in thyroparathyroidectomized and nephrectomized rats. Journal of the American Society of Nephrology 2001 12 764A.
17. Yamashita H, Gao P, Noguchi S, Cantor T, Uchino S, Watanabe S et al. Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay. Annals of Surgery 2002 236 105-111.
18. Yamashita H, Noguchi S, Futata T, Mizukoshi T, Uchino S, Watanabe S et al. Usefulness of quick intraoperative measurements of intact parathyroid hormone in the surgical management of hyperparathyroidism. Biomedicine and Pharmacotherapy 2000 54 108s-111s.
19. Reitz RE, Pollard JJ, Wang CA, Fleischli DJ, Cope O, Murray TM et al. Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay. New England Journal of Medicine 1969 281 348-351.
20. Taylor J, Fraser W, Banaszkiewicz P, Drury P & Atkins P. Lateralization of parathyroid adenomas by intra-operative parathormone estimation. Journal of the Royal College Surgeons of Edinburgh 1996 41 174-177.
21. Bergenfelz A, Alogotsson L, Roth B, Isaksson A & Tibblin S. Side localization of parathyroid adenomas by simplified intraoperative venous sampling for parathyroid hormone. World Journal of Surgery 1996 20 358-360.
22. Cohen A, LoGerfo P, Gao P, Brown IN, Trokan S, Cantor T et al. PTH(1-84) and N-truncated PTH fragment in the serum and parathyroid glands of patients with primary hyperparathyroidism. Journal of Bone and Mineral Metabolism 2001 16 S156.
23. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R & D'Amour P. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology 2001 142 1386-1392.
24. Divieti P, John MR, Juppner H & Bringhurst FR. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002 143 171-176.
25. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA & Potts JJ. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 1988 104 1121-1127.
26. McHenry CR, Pollard A, Walfish PG & Rosen IB. Intraoperative parathormone level measurement in the management of hyperparathyroidism. Surgery 1990 108 801-808.
27. Irvin GL, Dembrow VD & Prudhomme DL. Clinical usefulness of an intraoperative 'quick parathyroid hormone' assay. Surgery 1993 114 1019-1023.
28. Kao PC, van Heerden JA & Taylor RL. Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clinic Proceedings 1994 69 532-537.